Sanara MedTech Inc. reported an 8% increase in net revenue to $28.4 million for Q3 2026, driven by growth in soft tissue repair products. Despite strong gross margins of 93%, the company posted a net loss of $1.3 million due to $3 million in legal and advisory expenses related to its pending merger with MiMedx Group. Adjusted EBITDA improved to $5.6 million, reflecting operational growth. Sanara updated its full-year 2026 revenue guidance to $110-$115 million, anticipating continued growth post-merger.
Sanara MedTech Inc.'s third quarter 2026 financial results provide context for readers following healthcare companies. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 13, 2026 04:11 WIB: out of 150 priced US health-sector stocks tradable on Pluang, 23 rose and 124 fell today. Notable movers include Moderna, Inc. (MRNA) at USD 230.95 with a 1-day change of -7.13% and a typical hold time on Pluang of 58 days, Butterfly Network Inc. Class A (BFLY) at USD 6.64 down 7.00%, and Recursion Pharmaceuticals Inc. (RXRX) at USD 3.34 down 6.96% with a balanced Pluang order activity of 50% Sell / 50% Buy.
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
Cisco is set to report its fiscal Q1 2027 earnings with a focus on cloud growth and AI demand. Analysts expect revenue around $18.1 billion, operating income of $6.5 billion, and earnings per share of $1.33, reflecting strong year-over-year growth. T...
BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...
